Akebia Therapeutics, Inc. (Nasdaq:AKBA)
Health Care/Life Sciences • Pharmaceuticals
CIK 1517022
Company
Akebia Therapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapeutics for patients with kidney diseases. The firm is also involved in the development and commercialization of drugs for the treatment of renal and metabolic disorders. Its products include Auryxia and Vadadustat. The company was founded by Joseph H. Gardner, John M. Rice, Michael E. Pape, Josh P. Fairbank, and Robert A. Shalwitz on February 27, 2007 and is headquartered in Cambridge, MA.
Address
245 First Street
Suite 1400
Cambridge, Massachusetts 02142
245 First Street
Suite 1400
Cambridge, Massachusetts 02142
Employees
205
205
Stock Info
Close
$1.6000
$1.6000
Day Range
1.5800 - 1.6591
1.5800 - 1.6591
52 Week Range
0.4901 - 1.8400
0.4901 - 1.8400
Average volume
1.96M
1.96M
Short Interest
8M (02/15/24)
8M (02/15/24)
% of Float Shorted
4.83%
4.83%
Market Cap
$305.19M
$305.19M
Revenue
$292.48M
$292.48M
Net Income
-$94.23M
-$94.23M
2020 Sales Growth
N/A
N/A
Key Executives
Board Of Directors
President, Chief Executive Officer & Director John P Butler MBA |
Chairman Adrian Adams |
Independent Director LeAnne M Zumwalt |
Independent Director Ronald E Frieson MBA |
Independent Director Myles Wolf MD |
Independent Director Steven C Gilman PhD |
Independent Director Michael W Rogers MBA |
Independent Director Cynthia Smith MBA |
SEC filings
Date | Form | Event |
---|---|---|
8 Nov, 2024 | SC 13G | |
7 Nov, 2024 | 8-K | |
7 Nov, 2024 | 10-Q | |
22 Oct, 2024 | 8-K | |
22 Oct, 2024 | SC 13G | |
16 Oct, 2024 | 8-K | |
12 Sep, 2024 | EFFECT | |
10 Sep, 2024 | CORRESP | |
9 Sep, 2024 | UPLOAD | |
3 Sep, 2024 | S-3 | |
8 Aug, 2024 | 10-Q | |
8 Aug, 2024 | 8-K | |
11 Jul, 2024 | 8-K | |
2 Jul, 2024 | 4 | |
26 Jun, 2024 | 3 | |
24 Jun, 2024 | 8-K | |
10 Jun, 2024 | 4 | |
10 Jun, 2024 | 4 | |
10 Jun, 2024 | 4 | |
10 Jun, 2024 | 8-K | |
10 Jun, 2024 | 4 | |
10 Jun, 2024 | 4 | |
10 Jun, 2024 | 4 | |
10 Jun, 2024 | 4 | |
14 May, 2024 | 4 | |
14 May, 2024 | 4 | |
13 May, 2024 | 144 | |
13 May, 2024 | 144 | |
9 May, 2024 | 10-Q | |
9 May, 2024 | 8-K | |
9 May, 2024 | 4 | |
25 Apr, 2024 | DEFA14A | |
25 Apr, 2024 | DEF 14A | |
25 Apr, 2024 | ARS | |
23 Apr, 2024 | 8-K | |
16 Apr, 2024 | 8-K | |
28 Mar, 2024 | 8-K | |
15 Mar, 2024 | 8-K | CEO Change |
14 Mar, 2024 | 10-K | |
14 Mar, 2024 | 8-K | |
1 Mar, 2024 | 4 | |
1 Mar, 2024 | 4 | |
1 Mar, 2024 | 4 | |
1 Mar, 2024 | 4 | |
29 Feb, 2024 | 4 | |
29 Feb, 2024 | 144 | |
29 Feb, 2024 | 144 | |
29 Feb, 2024 | 144 | |
29 Feb, 2024 | 144 | |
29 Feb, 2024 | 4 | |
29 Feb, 2024 | 4 | |
29 Feb, 2024 | 4 | |
27 Feb, 2024 | 144 | |
27 Feb, 2024 | 144 | |
27 Feb, 2024 | 144 | |
27 Feb, 2024 | 144 | |
13 Feb, 2024 | 8-K | |
13 Feb, 2024 | SC 13G/A | |
9 Feb, 2024 | SC 13G/A | |
2 Feb, 2024 | 4 | |
2 Feb, 2024 | 4 | |
2 Feb, 2024 | 4 | |
2 Feb, 2024 | 4 | |
2 Feb, 2024 | 4 | |
2 Feb, 2024 | 4 | |
2 Feb, 2024 | 4 | |
1 Feb, 2024 | 144 | |
1 Feb, 2024 | 144 | |
30 Jan, 2024 | 8-K | |
30 Jan, 2024 | S-8 | |
18 Jan, 2024 | 3 | |
18 Jan, 2024 | 3 | |
8 Jan, 2024 | 8-K | |
8 Jan, 2024 | 8-K | |
18 Dec, 2023 | 8-K | |
21 Nov, 2023 | 8-K | |
8 Nov, 2023 | 8-K | |
8 Nov, 2023 | 10-Q | |
2 Nov, 2023 | 8-K | |
25 Oct, 2023 | 8-K | |
12 Oct, 2023 | 8-K | |
26 Sep, 2023 | 8-K | |
28 Aug, 2023 | 10-K/A | |
28 Aug, 2023 | 10-Q | |
25 Aug, 2023 | 8-K | |
17 Aug, 2023 | 8-K | |
11 Aug, 2023 | 8-K | |
10 Aug, 2023 | NT 10-Q | |
1 Aug, 2023 | 8-K | |
1 Aug, 2023 | 4 | |
18 Jul, 2023 | 8-K | |
18 Jul, 2023 | 3 | |
13 Jun, 2023 | 8-K | CEO Change |
8 Jun, 2023 | 4 | |
8 Jun, 2023 | 4 | |
8 Jun, 2023 | 4 | |
8 Jun, 2023 | 4 | |
8 Jun, 2023 | 4 | |
8 Jun, 2023 | 4 | |
8 Jun, 2023 | 8-K | |
8 Jun, 2023 | 4 | |
7 Jun, 2023 | 8-K | |
6 Jun, 2023 | S-8 | |
2 Jun, 2023 | 8-K | |
31 May, 2023 | 8-K | |
30 May, 2023 | 8-K | |
25 May, 2023 | 4 | |
25 May, 2023 | 144 | |
25 May, 2023 | 144 | |
25 May, 2023 | 8-K | |
25 May, 2023 | 4 | |
23 May, 2023 | 8-K | |
18 May, 2023 | 4 | |
18 May, 2023 | 4 | |
16 May, 2023 | 4 | |
16 May, 2023 | 144 | |
16 May, 2023 | 144 | |
16 May, 2023 | 4 | |
9 May, 2023 | 8-K | |
8 May, 2023 | 10-Q | |
8 May, 2023 | 8-K | |
8 May, 2023 | 8-K | |
28 Apr, 2023 | DEF 14A | |
28 Apr, 2023 | ARS | |
28 Apr, 2023 | 8-K | |
25 Apr, 2023 | 8-K | |
21 Apr, 2023 | DEFA14A | |
14 Apr, 2023 | DEFA14A | |
14 Apr, 2023 | DEFA14A | |
11 Apr, 2023 | 8-K | |
11 Apr, 2023 | DEFA14A | |
31 Mar, 2023 | DEFA14A | |
27 Mar, 2023 | DEFA14A | |
27 Mar, 2023 | DEFA14A | |
27 Mar, 2023 | DEFA14A | |
24 Mar, 2023 | DEFA14A | |
17 Mar, 2023 | DEFR14A | |
10 Mar, 2023 | 10-K | |
9 Mar, 2023 | 8-K | |
3 Mar, 2023 | 4 | |
3 Mar, 2023 | 4 | |
3 Mar, 2023 | 4 | |
3 Mar, 2023 | 4 | |
3 Mar, 2023 | 4 | |
2 Mar, 2023 | 8-K | |
1 Mar, 2023 | 4 | |
1 Mar, 2023 | DEF 14A | |
1 Mar, 2023 | 4 | |
1 Mar, 2023 | 4 | |
1 Mar, 2023 | 4 | |
1 Mar, 2023 | 4 | |
21 Feb, 2023 | 8-K | |
17 Feb, 2023 | PRE 14A | |
10 Feb, 2023 | SC 13G/A | |
9 Feb, 2023 | SC 13G/A | |
2 Feb, 2023 | 4 | |
2 Feb, 2023 | 4 | |
2 Feb, 2023 | 4 | |
30 Jan, 2023 | S-8 | |
20 Jan, 2023 | SC 13G/A | |
9 Jan, 2023 | 8-K | |
28 Dec, 2022 | 8-K | |
19 Dec, 2022 | SC 13G | |
15 Dec, 2022 | 8-K | |
13 Dec, 2022 | CT ORDER | |
10 Nov, 2022 | 8-K | |
8 Nov, 2022 | 8-K | |
3 Nov, 2022 | 8-K | |
3 Nov, 2022 | 10-Q | |
7 Oct, 2022 | CT ORDER | |
1 Sep, 2022 | 4 | |
4 Aug, 2022 | 8-K | |
4 Aug, 2022 | 10-Q | |
18 Jul, 2022 | 8-K | |
8 Jul, 2022 | SC 13G | |
30 Jun, 2022 | 8-K | |
10 Jun, 2022 | 8-K | |
10 Jun, 2022 | 4 | |
9 Jun, 2022 | 4 | |
9 Jun, 2022 | SC 13G/A | |
9 Jun, 2022 | 4 | |
9 Jun, 2022 | 4 | |
9 Jun, 2022 | 4 | |
9 Jun, 2022 | 4 | |
9 Jun, 2022 | 4 | |
9 Jun, 2022 | 4 | |
7 Jun, 2022 | 4 | |
16 May, 2022 | 4 | |
16 May, 2022 | 4 | |
13 May, 2022 | 8-K | |
9 May, 2022 | 8-K | |
9 May, 2022 | 10-Q | |
28 Apr, 2022 | DEFA14A | |
28 Apr, 2022 | DEF 14A | |
28 Apr, 2022 | EFFECT | |
7 Apr, 2022 | 424B5 | |
7 Apr, 2022 | 424B5 | |
7 Apr, 2022 | 8-K | |
7 Apr, 2022 | 8-K | |
30 Mar, 2022 | 8-K | |
18 Mar, 2022 | CT ORDER | |
2 Mar, 2022 | 4 | |
2 Mar, 2022 | 4 | |
2 Mar, 2022 | 4 | |
2 Mar, 2022 | 4 | |
2 Mar, 2022 | 4 | |
2 Mar, 2022 | 4 | |
2 Mar, 2022 | 4 | |
1 Mar, 2022 | POSASR | |
1 Mar, 2022 | 10-K | |
1 Mar, 2022 | POS AM | |
1 Mar, 2022 | 8-K | |
22 Feb, 2022 | 8-K | |
18 Feb, 2022 | 4/A | |
10 Feb, 2022 | SC 13G/A | |
9 Feb, 2022 | SC 13G/A | |
7 Feb, 2022 | SC 13G/A | |
28 Jan, 2022 | S-8 | |
24 Jan, 2022 | 8-K | |
5 Jan, 2022 | 4 | |
30 Dec, 2021 | CT ORDER | |
15 Dec, 2021 | 8-K/A | |
4 Nov, 2021 | 10-Q | |
4 Nov, 2021 | 8-K | |
3 Nov, 2021 | 3 | |
3 Nov, 2021 | 4 | |
1 Nov, 2021 | 8-K | |
1 Oct, 2021 | 4 | |
28 Sep, 2021 | 8-K | |
9 Sep, 2021 | 8-K | |
2 Sep, 2021 | 4 | |
24 Aug, 2021 | 8-K | |
10 Aug, 2021 | SC 13G/A | |
5 Aug, 2021 | 8-K | |
5 Aug, 2021 | 10-Q | |
12 Jul, 2021 | SC 13G/A | |
9 Jun, 2021 | 4 | |
3 Jun, 2021 | 4 | |
3 Jun, 2021 | 4 | |
3 Jun, 2021 | 4 | |
3 Jun, 2021 | 4 | |
3 Jun, 2021 | 8-K | |
3 Jun, 2021 | 4 | |
3 Jun, 2021 | 4 | |
1 Jun, 2021 | 8-K | |
10 May, 2021 | 10-Q | |
10 May, 2021 | 8-K | |
22 Apr, 2021 | DEF 14A | |
22 Apr, 2021 | DEFA14A | |
1 Apr, 2021 | 4 | |
1 Apr, 2021 | 4 | |
1 Apr, 2021 | 4 | |
1 Apr, 2021 | 4 | |
1 Apr, 2021 | 4 | |
1 Apr, 2021 | 4 | |
30 Mar, 2021 | 8-K | |
18 Mar, 2021 | 4 | |
18 Mar, 2021 | 4 | |
18 Mar, 2021 | 4 | |
18 Mar, 2021 | 4 | |
18 Mar, 2021 | 4 | |
18 Mar, 2021 | 4 | |
2 Mar, 2021 | 4 | |
2 Mar, 2021 | 4 | |
2 Mar, 2021 | 4 | |
2 Mar, 2021 | 4 | |
2 Mar, 2021 | 4 | |
2 Mar, 2021 | 4 | |
2 Mar, 2021 | 4 | |
25 Feb, 2021 | 8-K | |
25 Feb, 2021 | 10-K | |
25 Feb, 2021 | S-3ASR | |
18 Feb, 2021 | 8-K | |
18 Feb, 2021 | 3 | |
18 Feb, 2021 | 4 | |
17 Feb, 2021 | 8-K | |
12 Feb, 2021 | SC 13G/A | |
11 Feb, 2021 | SC 13G | |
10 Feb, 2021 | SC 13G | |
10 Feb, 2021 | SC 13G/A | |
3 Feb, 2021 | SC 13G/A | |
29 Jan, 2021 | SC 13G/A | |
28 Jan, 2021 | 8-K | |
28 Jan, 2021 | 3 | |
22 Jan, 2021 | S-8 | |
12 Jan, 2021 | 8-K |
Last update:2024-03-06 12:26:12.922766
Sign Up to Subscribe
Interested in special situations?
Join Tickerverse
- customize event filters
- create watchlists, bookmarks
- get email notifications for the latest special situations
- browse and analyze public companies, executives and SEC filings
Tickerverse is a great way to find investment opportunities in corporate actions.
By signing up you agree to our Terms of Service and Privacy Policy.